Mesa Laboratories Reports Revenue Growth Amid Rising Costs and Declining Operating Income

Mesa Laboratories, Inc. (NASDAQ: MLAB) has released its financial performance report for the quarter ending June 30, 2025. The report outlines both promising growth and some concerning financial trends.

Positive Aspects:

• Revenue Growth: Total revenues increased to $59.5 million, a 2.4% rise from $58.2 million in the same quarter of the previous year.
• Net Income Improvement: Net income rose 40.0% to $4.74 million, up from $3.39 million year-over-year.
• Earnings Per Share: Basic earnings per share increased to $0.87, compared to $0.63 in the prior year.
• Stable Gross Profit: While gross profit slightly decreased, it remains strong at $36.94 million (62.0% of revenues), demonstrating resilience despite rising costs.
• Strong Performance in Sterilization and Disinfection Control: This segment reported a 10.7% revenue increase driven by higher sales volumes.

Negative Aspects:

• Rising Operating Expenses: Total operating expenses escalated by 7.0% from the prior year, rising to $33.88 million, which contributed to lower operating income of $3.06 million (down 45.1% year-over-year).
• Increased Non-Operating Expenses: Non-operating expenses included foreign currency adjustments leading to a net expense of $3.95 million, significantly worsening the financial position compared to a net gain last year.
• High Effective Tax Rate: The effective tax rate increased to 32.4%, substantially higher than the previous year's 13.2%, impacting overall net income.
• Negative Working Capital: Working capital was negative at $(51.2) million primarily due to the classification of convertible notes as current liabilities.

Key Statistics:

• Revenues: $59,543 (Q1 2025) vs. $58,170 (Q1 2024)
• Operating Income: $3,064 (Q1 2025) vs. $5,580 (Q1 2024)
• Net Income: $4,742 (Q1 2025) vs. $3,388 (Q1 2024)
• Earnings per Share: Basic: $0.87 | Diluted: $0.85
• Total Assets: $435.7 million as of June 30, 2025
• Total Liabilities: $263.2 million as of June 30, 2025

This financial outlook indicates that while MESA LABORATORIES, INC. is experiencing growth in revenue and earnings, rising costs and operating expenses are areas of concern that could affect future performance. Investors should monitor these trends closely as the company navigates through economic pressures and industry competition.